• Western blot analysis of lysates from SH-SY5Y cells, primary antibody was diluted at 1:1000, 4°C over night

Anti-NDUFA12 antibody (80-160 aa) (STJ191023)

SKU:
STJ191023

Current Stock:
Host: Rabbit
Applications: WB/ELISA
Reactivity: Human/Mouse
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Short Description: Rabbit polyclonal antibody anti-NADH dehydrogenase 1 alpha subcomplex subunit 12 (80-160 aa) is suitable for use in Western Blot and ELISA research applications.
Clonality: Polyclonal
Conjugation: Unconjugated
Isotype: IgG
Formulation: Liquid in PBS containing 50% Glycerol and 0.02% Sodium Azide.
Purification: The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
Concentration: 1 mg/mL
Dilution Range: WB 1:500-2000
ELISA 1:5000-20000
Storage Instruction: Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles.
Gene Symbol: NDUFA12
Gene ID: 55967
Uniprot ID: NDUAC_HUMAN
Immunogen Region: 80-160 aa
Specificity: NDUAC Polyclonal Antibody detects endogenous levels of protein.
Immunogen: Synthesized peptide derived from the human protein at the amino acid range 80-160
Protein Name Nadh Dehydrogenase Ubiquinone 1 Alpha Subcomplex Subunit 12
13 Kda Differentiation-Associated Protein
Complex I-B17.2
Ci-B17.2
Cib17.2
Nadh-Ubiquinone Oxidoreductase Subunit B17.2
Database Links Reactome: R-HSA-611105
Reactome: R-HSA-6799198
Cellular Localisation Mitochondrion Inner Membrane
Peripheral Membrane Protein
Matrix Side
Alternative Antibody Names Anti-Nadh Dehydrogenase Ubiquinone 1 Alpha Subcomplex Subunit 12 antibody
Anti-13 Kda Differentiation-Associated Protein antibody
Anti-Complex I-B17.2 antibody
Anti-Ci-B17.2 antibody
Anti-Cib17.2 antibody
Anti-Nadh-Ubiquinone Oxidoreductase Subunit B17.2 antibody
Anti-NDUFA12 antibody
Anti-DAP13 antibody

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance